Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

Conditions:   Uterine Cervical Neoplasms;   Chemoradiotherapy;   Angiogenesis Interventions:   Drug: Hydrochloride anlotinib;   Drug: cis Platinum/carboplatin;   Radiation: External beam radiotherapy and brachytherapy Sponsor:   Zhongnan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials